ATAI Life Sciences N.V.

Ownership Transactions Reported by 17 Insiders

Symbol
ATAI on Nasdaq
Location
Wallstrasse 16, Berlin, Germany

Insiders trading volume in the past year

ATAI Life Sciences N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Florian Brand Co-Founder & Co-Chief Executive Officer $636K -$291K -31.4% Oct 4, 2024
Srinivas Rao Co-Founder & Co-Chief Executive Officer $216K -$114K -34.5% Oct 4, 2024
Anne Nagengast Johnson Chief Financial Officer $136K -$50.7K -27.1% Oct 4, 2024
Sahil Kirpekar Chief Business Officer $119K -$66.2K -35.8% Apr 2, 2024
Apeiron Investment Group Ltd. 10%+ Owner Apr 15, 2024
Amir H. Kalali Director Jun 13, 2024
Alexis de Rosnay Director May 25, 2022
Christian Angermayer Director, 10%+ Owner Oct 4, 2024
Rolando Gutierrez-Esteinou Chief Medical Officer Mar 14, 2023
Stephen Bardin Chief Financial Officer Mar 14, 2023
Andrea Heslin Smiley Director Jun 13, 2024
Jason Camm Director May 23, 2023
Laurent Fischer Director Jun 13, 2024
Michael Auerbach Director Jun 13, 2024
Scott Braunstein Director Jun 13, 2024
Gregory L. Weaver Chief Financial Officer Mar 2, 2022
Sabrina Martucci Johnson Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for ATAI Life Sciences N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.